Found 14 matching trials
The Hemophilia Inhibitor Prevention Trial PHASE3 This is a multi-center randomized phase III clinical trial, the Inhibitor P...
Show More Location
University of Arkansas Medical Sciences Childrens Hospital
Learn More & Join Trial
Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies PHASE4 The primary purpose of this study is to describe the outcome of Immune Tole...
Show More Location
Swedish Orphan Biovitrum Research Site
Learn More & Join Trial
An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A PHASE3 The primary objective of the study was to evaluate the safety of rFVIIIFc (...
Show More Learn More & Join Trial
Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale PHASE3 The primary objective of the study is to compare the pharmacokinetic (PK) o...
Show More Learn More & Join Trial
Health Related Quality of Life of Youth and Young Adults With Haemophilia A PHASE4 Research question:
Whether there are the changes in quality of life in pat...
Show More Location
League of Clinical Research (LeagueCRR)
Learn More & Join Trial
Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform PHASE3 This study will evaluate if Eloctate is superior to Emicizumab in reducing ...
Show More Location
Hemophilia Center of Western Pennsylvania
Learn More & Join Trial
Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products N/A The purpose of the study is to evaluate the effectiveness of Elocta compare...
Show More Location
Swedish Orphan Biovitrum Research site
Learn More & Join Trial
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies PHASE4 This is a prospective, randomized control trial in which each patient will ...
Show More Location
The University of Texas Southwestern Medical Center
Learn More & Join Trial
Weight-based Dosing in Hemophilia A PHASE2 Hemophilia A is an inherited (genetic) disease where a protein, factor VIII...
Show More Location
Hemophilia Center of Western Pennsylvania
Learn More & Join Trial
Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A PHASE3 The primary objective of the study is to evaluate the long-term safety of r...
Show More Learn More & Join Trial